The simian double strand DNA tumor virus SV40 encodes the 90-kDa multi-functional protein, large T antigen (LT). LT functions by binding to DNA, as well as to many cellular target proteins such as p53 and retinoblastoma protein (pRB). We report here the identi®cation of a cellular heat shock protein, HSP90, as a previously undescribed LT-associated protein.
Introduction
The simian virus 40 (SV40) Large T antigen (LT) is a 90-kDa phosphoprotein that is essential for the viral replication and transformation of host cells (Fanning, 1992; Pipas, 1992; Ludlow, 1993) . LT possesses various biochemical functions such as ATP-binding, ATPase, DNA-binding, and DNA-helicase activities (Tjian et al., 1980; Pipas, 1992) . LT has been shown to bind to a series of host cellular proteins including p53 (Lane and Crawford, 1979; Linzer and Levine, 1979) , retinoblastoma family proteins, such as pRB and p107 (DeCaprio et al., 1988; Dyson et al., 1989) , DNApolymerase a (Smale and Tjian, 1986) , transcriptional coactivators (Avantaggiati et al., 1996) , and cyclin A and p33 cdk2 (Adamczewski et al., 1993) . Most of these molecules are known to regulate the cell cycle and cell growth, and the interaction of LT with these cellular proteins is crucial for tumorigenesis.
Many viral proteins are known to be associated with heat shock proteins (HSPs) or molecular chaperones of host cells. For example, HSP90 associates with viral oncoprotein pp60 v-src (Brugge et al., 1981; Oppermann et al., 1981) and hepatitis B virus reverse transcriptase (Hu and Seeger, 1996) . LT is reported to bind the major heat shock protein, HSP70 (Sawai and Butel, 1989) . More surprisingly, a previous study has demonstrated that the amino acid sequence of the Nterminal region of LT is homologous to the J domain of the DnaJ family of molecular chaperones (Kelley and Landry, 1994) . In fact, this region is capable of functioning as a J domain (Srinivasan et al., 1997) and is important for ecient viral DNA replication (Campbell et al., 1997) , all of which suggests a relationship between the LT function and molecular chaperones.
HSP90 is ubiquitously and abundantly distributed in all organisms from bacteria to humans. The amino acid sequence of HSP90 is highly conserved among species, suggesting that HSP90 plays a fundamental role in cells (Lindquist and Craig, 1988; Welch, 1992) . Signi®cant progress has been made recently on the structure and function of HSP90 (Csermely et al., 1998; Toft, 1998; Yahara et al., 1998; Buchner, 1999; Mayer and Bukau, 1999) , although the precise mechanism underlying the way in which HSP90 functions as a molecular chaperone remains largely unknown. HSP90 is known to interact with a variety of cellular and viral proteins (Rutherford and Zuker, 1994) . The most well-characterized cellular targets of HSP90 are transcription factors, such as steroid hormone receptors (Joab et al., 1984; Catelli et al., 1985; Sanchez et al., 1985) , MyoD1 (Shaknovich et al., 1992) , and heat shock factor (Zou et al., 1998) . Likely the largest family of HSP90-targets consists of protein kinases, such as casein kinase II (Miyata and Yahara, 1992) , Raf1 (Stancato et al., 1993) , sevenless tyrosine kinase (Cutforth and Rubin, 1994) , and Wee1 (Aligue et al., 1994) . The growing list of cellular targets of HSP90 now includes endothelial nitric oxide synthase (GarcõÂ a-CardenÄ a et al., 1998) and telomerase (Holt et al., 1999) .
Among the proteins associated with HSP90, of special interest are proteins that translocate from the cytosol to the nucleus, where they bind DNA. HSP90 has been suggested to modulate the function and subcellular distribution of target proteins. Functional folding, cellular localization, and DNA-binding of nuclear proteins have been shown to be regulated by HSP90 (Shaknovich et al., 1992; Hendrick and Hartl, 1993; Jakob and Buchner, 1994; Miyata and Yahara, 1995; Zou et al., 1998; Holt et al., 1999) . We report here evidence that SV40 LT is associated with HSP90 in vivo, and that this association can be reconstituted from puri®ed HSP90 and puri®ed unfolded LT in vitro. Consistent with this ®nding, the anti-cancer drug geldanamycin, which is known to function as an HSP90-speci®c inhibitor, decreased the intracellular amount of LT.
Results

Specificity of an antibody against LT and antibodies against HSP90
Crude cell extracts from parental CV1 and SV40-transformed COS7 cells were separately prepared. HSP90 and LT were puri®ed to homogeneity as described in Materials and methods. The cell lysates and the puri®ed proteins were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS ± PAGE) and Western blotting with anti-HSP90 or anti-LT antibodies. As shown in Figure 1a These ®ndings clearly indicated that antibodies to HSP90 and PAb419 speci®cally recognize only the corresponding target proteins. It should be noted that the two proteins showed nearly identical mobility on SDS polyacrylamide gels. We also con®rmed that these antibodies speci®cally immunoprecipitated the corresponding protein (data not shown).
Co-immunoprecipitation of HSP90 with LT
Cell extracts were prepared from three LT-expressing cell lines (COS1, COS7, and VA4) or from control cell lines (CV1 and HeLa). HSP90 was immunoprecipitated along with its associated proteins from cell extracts and resolved by SDS ± PAGE. Nearly equivalent amounts of HSP90 were immunoprecipitated from the extracts of these cell lines, as indicated by silver staining ( Figure  2a ). Western blotting of the immunoprecipitates with anti-LT (PAb419) revealed the presence of LT only in the HSP90-immunocomplexes from SV40-transformed cells (Figure 2b , lanes 3 ± 5). No signal was detected in the immunocomplexes from cell lines that do not express LT (Figure 2b, lanes 1 and 2) . LT and HSP90 were also co-immunoprecipitated from lysates of 3Y1 cells transformed with SV40 (A640-3Y1) and from those transformed with small t antigen-depleted SV40 (dl884-3Y1) (data not shown), indicating that the small t antigen is not responsible for this co-immunoprecipitation.
In a subsequent experiment, PAb419 was used to immunoprecipitate LT along with its associated proteins from the cell extracts described above, and the coimmunoprecipitation of HSP90 was examined by Western blotting. LT was immunoprecipitated only from extracts of LT-expressing cell lines as shown by silver staining (Figure 3a , lanes 3 ± 5). Western blotting with anti-HSP90 antibodies revealed that HSP90 was coimmunoprecipitated with LT from extracts of COS1, COS7, and VA4 cell lines (Figure 3b , lanes 3 ± 5) but not from those of CV1 and HeLa (Figure 3b , lanes 1 ± 2). These ®ndings taken together indicated that LT is associated with HSP90 in SV40-transformed cells.
Association between HSP90 and LT is p53-independent
In addition to the well-characterized association between LT and p53 (Lane and Crawford, 1979; Linzer and Levine, 1979) , HSP90 is also known to be associated with certain mutant forms of p53 (Blagosklonny et al., 1996; Whitesell et al., 1998) . Thus, the possibility exists that the observed co-immunoprecipitation of HSP90 with LT could be mediated by p53. We performed immunodepletion experiments to examine the role of p53 in the HSP90-LT association. When cell lysates were subjected to immunodepletion by anti-LT antibody, essentially all of the LT and p53 were removed from the lysates and no additional LT or p53 was immunoprecipitated from the immunodepleted lysates by corresponding antibodies (Figure 4a , lanes 4 ± 6). p53 was completely immunodepleted with antip53 antibody (Figure 4a , lane 8 and 9), whereas the majority of LT was still present in the lysates ( Figure  4a , lane 8). This may be explained by the fact that the intracellular amount of LT largely exceeds that of p53 in COS7 cells. Next, we examined the co-immunoprecipitation of HSP90 with LT using the immunodepleted cell lysates described above. An association between HSP90 and LT was clearly observed in the non-depleted lysates ( Figure We then examined if HSP70 is included in the immunocomplexes containing HSP90 and LT. Immunoprecipitates were prepared from COS7 cell lysates with antibodies against HSP90 or LT, and then the immunocomplexes were examined by Western blotting with anti-HSP70 antibody. As shown in Figure 4c , HSP70 was detected in both anti-HSP90 and anti-LT S-Met/Cys-labeled COS7 cell lysates were immunodepleted by anti-LT or anti-p53 antibody along with non-immune antibody as indicated on the top, and the depleted lysates were then used for immunoprecipitation with the antibodies indicated at the bottom. The immunoprecipitates were analysed by SDS ± PAGE and¯uoro-graphy. The positions of LT, p53, small t antigen, and a nonspeci®cally bound protein (indicated by an asterisk) are shown on the right, while the positions of molecular weight markers are shown on the left. (b) Co-immunoprecipitation of HSP90 with LT in the depleted lysates. COS7 cells were immunodepleted and then immunoprecipitated as described in (a), and the immunoprecipitates were examined for co-immunoprecipitation of HSP90 by Western blotting. A part of the membrane corresponding to *90 kDa is shown and the position of HSP90 is indicated. (c) Co-immunoprecipitation of HSP70 with LT and HSP90. Immunocomplexes were prepared from COS7 cell lysates with anti-LT or anti-HSP90 antibodies, and the immunoprecipitates were examined for co-immunoprecipitation of HSP70 by Western blotting. A part of the membrane is shown and the positions of HSP70 and immunoglobulin heavy chain (HC) are indicated immunocomplexes. This result is in good agreement with previous reports that LT is associated with HSP70 in other systems (Sawai and Butel, 1989; Yang and DeFranco, 1994) . It was dicult to completely immunodeplete HSP70 from the lysates because of its high abundance and we could not examine if HSP70 indirectly mediates the association between HSP90 and LT or not. Thus, we next tested the direct association of HSP90 with LT in an in vitro reconstitution system.
Reconstitution of LT-HSP90 complexes in vitro from HSP90 and unfolded LT, but not from native LT To test whether the LT-HSP90 complex can be reconstituted from HSP90 and LT in vitro, puri®ed LT and HSP90 were mixed and the association of the two proteins was then examined by co-immunoprecipitation experiments. However, the results obtained under various conditions were all negative (see Figure 5a , lane 5).
We then examined complex formation using native HSP90 and unfolded LT. Puri®ed LT was denatured with 8 M guanidine-HCl and divided into two parts. One part was then directly diluted 20-fold into a buer containing 0.25 mg/ml of HSP90 in the presence of a large excess of bovine serum albumin. The other part was ®rst incubated in the folding buer without HSP90 for 150 min at 308C, and then mixed with HSP90 under the same conditions as described above. Subsequently, reconstitution of LT-HSP90 complexes was examined by co-immunoprecipitation experiments. As shown in Figure 5a lane 2, LT-immunoprecipitates from the mixture of HSP90 and unfolded LT contained HSP90. The reconstituted complexes were observed as a very closely adjacent doublet (HSP90 as the upper band and LT as the lower band) by silver staining (Figure 5c, lane 2) . No reconstitution of HSP90-LT complexes was observed when either HSP90 or LT was omitted (Figure 5a, lanes 1 and 3) . Interestingly, the amount of co-immunoprecipitated HSP90 with LT was dramatically reduced when LT had been folded prior to mixing (compare lane 5 to lane 2 in Figure 5a ). Equivalent amounts of LT were immunoprecipitated from mixtures containing either unfolded LT or folded LT irrespective of the presence or absence of HSP90 (Figure 5b, lanes 1, 2, 4 , and 5). These results taken together clearly indicated that HSP90 has a higher anity for unfolded, denatured LT than for folded LT.
We attempted to determine whether ATP is required for LT-HSP90 reconstitution in the system described above. The addition of 3.3 mM ATP to the reconstitution system did not aect the co-precipitation of HSP90 with LT (data not shown). The addition of apyrase (up to 33 units/ml) to the mixture also did not aect the HSP90-LT reconstitution (data not shown). These results indicated that ATP is neither required for, nor inhibits the complex formation of LT with HSP90 in vitro.
Geldanamycin, an HSP90-inhibiting drug, decreased the intracellular amount of LT Geldanamycin, a benzoquinoid ansamycin-derivative drug (Uehara et al., 1986) , binds speci®cally to HSP90 and inhibits the chaperone-function of HSP90 (Whitesell et al., 1994) . To determine the requirement of the HSP90 function for maturation and stability of LT, COS7 cells were treated with 6 mM geldanamycin for 22 or 46 h and the amount of intracellular LT was then determined by Western blotting. In response to geldanamycin treatment for 46 h, the amount of LT was signi®cantly diminished (Figure 6b , lane 5), whereas the level of LT was not changed as a result of treatment for 22 h (Figure 6b, lane 3) . Raf1, a target of HSP90 which is known to be short-lived, was not detected following treatment with geldanamycin for 22 h (Figure 6d, lanes 3 and 5) . This dierential sensitivity to geldanamycin between LT and Raf1 may be attributable to a dierence in intracellular life duration and/or to a dierence in intracellular pool sizes. To more directly illustrate the eect of geldanamycin on LT, we determined the amount of newly synthesized LT by immunoprecipitating LT from COS7 cells that had been labeled with 35 S-methionine (Met)/cysteine(Cys). Following treatment with gelda- Figure 5 Reconstitution of HSP90-LT complexes in vitro. Unfolded LT (marked as`U' in lanes 1 and 2) was diluted (1 : 20) in a buer containing HSP90, and the reconstitution of LT-HSP90 complexes was examined by co-immunoprecipitation analysis. When indicated, unfolded LT was renatured ®rst (marked as`F' in lanes 4 and 5), and then mixed with HSP90. As a control, HSP90 was omitted in lanes 1 and 4, and LT was omitted in lanes 3 and 6. (Figure 6c , lane 5). The total incorporation of radioactivity into cellular proteins was not reduced in response to geldanamycin treatment (data not shown). In light of these results, we concluded that inhibition of cellular HSP90 function by geldanamycin lowered the stability and lifetime of newly synthesized LT, and ultimately led to a decrease in total LT following treatment for 46 h.
While the overall protein pro®les of cells did not change signi®cantly in response to geldanamycin treatment, the amount of 90-, 70-, and 30-kDa proteins were found to have increased signi®cantly after treatment (Figure 6a, lanes 3 and 5) . These proteins were identi®ed as HSP90, HSP70, and HSP27, respectively, by Western blotting experiments (data not shown). The above result is entirely consistent with those of previous reports whereby inhibition of HSP90 activates the heat shock transcription factor, HSF1 (Hedge et al., 1995; Zou et al., 1998) .
Discussion
Large T antigens are known to transform cells via an association with many kinds of cell cycle-regulating proteins (Fanning, 1992; Pipas, 1992; Ludlow, 1993) . In the present study, we newly identi®ed HSP90, a major cytosolic molecular chaperone, as a LT-associated cellular protein. No association between the 90-kDa protein and LT has previously been identi®ed, likely due to the fact that its molecular mass is almost the same as that of LT on SDS ± PAGE. We used immunological methods to detect the LT-HSP90 associations both in vitro and in vivo. The signi®cance of our ®ndings can be summarized by the following observations. (i) An antibody against LT co-precipitated HSP90. (ii) Antibodies against HSP90 co-precipitated LT. (iii) These coimmunoprecipitations were not observed in normal cells. (iv) LT-HSP90 complexes were reconstituted in vitro by mixing puri®ed HSP90 with puri®ed and unfolded LT without any additional protein components. (v) The anti-tumor drug geldanamycin, a known HSP90-speci®c inhibitor, decreased the amount of cellular LT.
One of the major LT-associated cellular proteins is p53 (Lane and Crawford, 1979; Linzer and Levine, 1979) . p53 is reported to be associated with HSP90 only when it is mutated (Blagosklonny et al., 1996; Whitesell et al., 1998) . In addition, HSP70 is known to be associated with both p53 (Pinhasi-Kimhi et al., 1986) and LT (Sawai and Butel, 1989) , and HSP90-containing complexes of functional proteins such as steroid hormone receptors are also associated with HSP70 (Csermely et al., 1998; Toft, 1998; Buchner, 1999; Mayer & Bukau, 1999) . Thus, the possibility exists that either p53 or HSP70 links HSP90 with LT. However, we excluded this possibility based on the following; LT is abundant compared to p53 in COS7 cells, and thus we could completely immunodeplete p53 without a signi®cant loss of LT. Even after p53 had previously been completely immunodepleted from cell lysates, we still detected the co-immunoprecipitation of HSP90 with LT (Figure 4 ). In addition, our reconstitution experiments clearly demonstrated that no other protein is required for the HSP90-LT association, at least in vitro, when LT is in a non-native conformation ( Figure 5 ). Thus, it is reasonable that the association between HSP90 and LT is direct, although the potential existence of ternary complexes such as LT-p53-HSP90 or LT-HSP70-HSP90 in vivo can not be excluded.
Our initial attempts to reconstitute the LT-HSP90 complexes from puri®ed LT and HSP90 were not successful under any of various conditions. We were able to reconstitute the complexes from native HSP90 and unfolded LT, suggesting that HSP90 recognizes a non-native LT. Our results also suggested that HSP90 binds and stabilizes newly synthesized LT. Previously, we determined an HSP90-binding site within casein kinase II (Miyata and Yahara, 1995) and the site contains a positively charged nuclear localization signal, which is highly homologous to that of LT (Kalderon et al., 1984) . Thus, the nuclear localization signal sequence of LT may be a candidate binding site for HSP90.
We estimated that 5 ± 10% of the total LT within the cells were co-immunoprecipitated with HSP90 (data not shown). Although the majority of LT is present in nuclei, a small portion of LT is found in the cytoplasm. Conversely, the majority of HSP90 is cytosolic. Thus, we suppose that LT might be associated with HSP90 in the cytosol. This type of the correlation between the intracellular distribution of target proteins and association with HSP90, is similar to the case for glucocorticoid receptors. Thus, as for glucocorticoid receptors, it might be possible that HSP90 plays a role in cytoplasmic anchoring of LT or in the nuclear import process of LT.
The cooperative function of several molecular chaperones including HSP70 and HSP90 may be required for the correct folding of target proteins (Welch, 1992; Schumacher et al., 1994; Frydman and HoÈ hfeld, 1997; Buchner, 1999) . HSP70 is reported to aect the structure of LT, and to complement the localization and functional defects of a LT mutant (Jeoung et al., 1991) . HSP90 is also reported to aect the conformation of several substrate proteins (Miyata and Yahara, 1992; Shaknovich et al., 1992; Wiech et al., 1992) . Thus, HSP90 and HSP70 may both play important roles in the folding and nuclear translocation of LT in vivo.
Materials and methods
Cell lines and culture conditions
The cell lines used in this study were HeLa (human), CV1 (monkey), 3Y1 (rat), and SV40-transformed cell lines including WI26VA4 (human), COS1/COS7 (monkey), A640-3Y1 (rat), and dl884-3Y1 (rat). All cell lines were cultured in Dulbecco's modi®ed MEM (Gibco-BRL) supplemented with 10% fetal calf serum. PAb419, a hybridoma cell line producing an antibody against SV40 LT (Harlow et al., 1981) , was maintained in ASF104 medium (Ajinomoto) supplemented with 10% fetal calf serum. WI26VA4, CV1, and COS1 were obtained from JCRB cell bank, A640-3Y1 and dl884-3Y1 (Kimura et al., 1975) from RIKEN cell bank with the permission of Dr G Kimura, and PAb419 from RIKEN cell bank with the permission of Dr Y Murakami.
Buffers
IPW buer: 20 mM Tris-HCl, 50 mM NaCl, 2 mM ethylenediaminetetraacetic acid (EDTA), 10 mM sodium pyrophosphate, pH 7.4. Tris-buered saline (TBS); 20 mM Tris-HCl, 500 mM NaCl, pH 7.4. Phosphate-buered saline (PBS); 10 mM sodium phosphate, 150 mM NaCl, pH 7.4.
Antibodies
Rabbit anti-HSP90 antiserum has been described previously (Koyasu et al., 1986) . Anti-LT monoclonal antibody PAb419 was puri®ed from culture supernatants of the hybridoma PAb419 with a protein G-sepharose column (Pharmacia). Anti-p53 antibody (clone 421) and anti-Raf1 antibody (R19120) were obtained from Oncogene Science and Transduction Laboratories, respectively. Anti-HSP70 antibody (clone N27F3-4) and anti-HSP27 antibody (clone G3.1) were obtained from StressGen.
Cell extracts
Cells cultured in 10 cm dishes were extracted in a 400 ml/dish of an IPW buer containing 0.1% NP40 supplemented with 10 mg/ml of aprotinin, 1 mM of phenylmethylsulfonyl¯uoride (PMSF), and 2 mg/ml of leupeptin. The lysates were centrifuged at 5000 g for 10 min and further at 100 000 g for 60 min at 28C. The resulting supernatants were used as soluble cell extracts for Western blotting and immunoprecipitation.
Western blotting
Proteins were resolved by SDS ± PAGE and electrotransferred to polyvinylidene di¯uoride (PVDF) membranes, which were then treated with 5% skimmed milk in TBS containing 0.05% Tween 20 (TBS+Tw) at room temperature for 60 min. The membranes were incubated for 3 h at 378C or overnight at 48C with appropriate antibodies, washed three times with TBS+Tw, and incubated with alkaline-phosphatase-conjugated secondary antibodies (Bio-Rad) for 60 min at 378C. The membranes were stained with an alkalinephosphatase substrate kit (Vector). In the experiment shown in Figure 4b , horseradish peroxidase-conjugated secondary antibody (Amersham) was used and the membrane was developed using chemiluminescence detection reagents (NEN Life Science Products).
Immunoprecipitation
Cell extracts were precleared by mixing with nonimmune serum and protein G-sepharose beads. The precleared lysates were incubated with appropriate antibodies at 48C for 12 h. Protein G-sepharose was then added to the mixtures and gently rocked for 60 min at 48C. The beads were washed ®ve times with an IPW buer containing 0.1% NP40, and the resulting immunoprecipitates were analysed by SDS ± PAGE and Western blotting.
Proteins
HSP90 was puri®ed from mouse L5178Y and monkey COS7 cells as described previously (Koyasu et al., 1986; Miyata and Yahara, 1992) . LT was puri®ed according to a method previously described (Dixon and Nathans, 1985; Simanis and Lane, 1985) with some modi®cations. Brie¯y, COS7 cells were extracted in an IPW buer containing 1% NP-40, and the extract was applied onto a DEAE-sepharose (Pharmacia) column. Bound proteins were eluted by a linear gradient of NaCl (100 ± 1000 mM) in Buer A (50 mM Tris-HCl, 2 mM EDTA, 10 mM sodium pyrophosphate, 1 mM dithiothreitol (DTT), and 10% glycerol, pH 7.4). Anti-LT monoclonal antibody (PAb419) was covalently conjugated to protein Asepharose using ImmunoPure IgG Orientation Kit (Pierce). DEAE-fractions containing LT were collected and passed through a protein A-sepharose column to remove proteins that non-speci®cally bind to protein A-sepharose, and then applied onto the PAb419-protein A-sepharose column. Unbound proteins were thoroughly washed-out by buer A containing 500 mM LiCl and the immuno-adsorbed LT was eluted from the column with a buer containing 20 mM triethylamine, 1 mM DTT, 2 mM EDTA, 100 mM NaCl, and 10% glycerol, pH 11. Immuno-puri®ed LT was further puri®ed and concentrated by a MonoQ column using a NaCl gradient (100 ± 1000 mM) in buer A. The puri®ed LT was homogeneous as a 90-kDa band as judged by SDS ± PAGE and silver staining. The yield was estimated to be approximately 50 mg from 64 dishes (10 cm) of COS7 cells.
Immunodepletion of p53 from COS7 lysates
The culture medium was changed to Met/Cys-free DMEM containing 10% fetal calf serum for 8 h, and the same medium containing 6 MBq/dish of Tran 35 S-label (NEN) was then added. Cell lysates were prepared from labeled COS7 cells and immunodepletion was performed by immunoprecipitating twice with the indicated antibodies. The resulting immuno-depleted supernatants were further used for immunoprecipitation with still other antibodies and the coimmunoprecipitation of associated proteins was examined bȳ uorography or by Western blotting.
Reconstitution of LT-HSP90 complexes in vitro
LT was immunologically isolated from COS7 lysates with PAb419-coupled Protein A-Sepharose beads as described above and the beads were washed extensively with an IPW buer containing 1 mM DTT, 1% NP40, and 1000 mM NaCl to remove any LT-associated proteins. LT was eluted from the beads with a solution containing 8 M guanidine-HCl and 50 mM Tris-HCl, pH 7.4, and stored on ice as`unfolded-LT'. The unfolded-LT was diluted (1 : 20) in a reconstitution solution and incubated at 308C for 150 min in the presence or absence of HSP90 and ATP. The ®nal composition of the reconstitution solution was 5 mM Tris-HCl, 400 mM guanidine-HCl, 7.5 mM creatine phosphate, 40 mg/ml creatine phosphokinase, 1.5 mM DTT, 60 mM potassium phosphate, 25 mM KCl, 3.5 mM MgCl 2 , 0.42 mg/ml bovine serum albumin, 15 mM hemin, 0.08 mM EDTA, 1% glycerol, and 4 mM NaCl, pH 7.4, in the presence or absence of 0.25 mg/ ml of HSP90 and/or 3.3 mM ATP. When indicated, LT was ®rst folded without HSP90 in the above solution for 150 min at 308C prior to the addition of HSP90. The reconstitution mixtures were then diluted eightfold with an IPW buer containing 0.1% NP40 and the association of HSP90 with LT was examined by co-immunoprecipitation experiments as described above.
Geldanamycin treatment of cells
Stock geldanamycin (10 mg/ml) was prepared in dimethyl sulfoxide (DMSO). COS7 cells were treated with 6 mM geldanamycin (control cells were mock-treated with the same concentration of DMSO vehicle) for the indicated time at 378C in the culture medium. Cell extraction, immunoprecipitation, and Western blotting of treated samples were performed as described above. For the 35 S-Met/Cys labeling, geldanamycin was added in the Met/Cys-free DMEM containing 10% fetal calf serum and then cells were pulselabeled by adding Tran 35 S-label during the last 4 h of incubation.
